Previous studies have shown the effect of chemotherapeutic regimens on tumor immune microenvironment, including an increase in infiltration of CD8+ T cells, CD3+ T cells, CD20+ B cells, and PD-1+ cells (13–15, 19, 20). This evidence concerns the gene CD8A and neoplasm.